A retrospective study of efficacy of onabotulinumtoxinA (BT-A) for chronic migraine (CM) in men compared with women
Latest Information Update: 29 Sep 2021
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Migraine
- Focus Therapeutic Use
- 29 Sep 2021 New trial record
- 12 Sep 2021 Results presented at The International Headache Congress - International Headache Society with the European Headache Federation Joint Congress 2021